Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS-747S Phase III Trial in Elective PCI
jRCT2080221511Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prasugrel in coronary arteriosclerosis (2 arms), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
prasugrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on jRCT2080221511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221511.